Journal of Urologic Oncology

Bladder Cancer

The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer: Jong Ho Park, Jong Jin Oh; Journal of Urologic Oncology. 2024;22(3):246-255. Published online November 30, 2024; DOI: https://doi.org/10.22465/juo.244800540047
Cited By 1; Full text PubReader ePub PDF

Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma

The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects: Hyerim Ha, Joo Han Lim; Journal of Urologic Oncology. 2023;21(3):208-216. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600540027
Cited By 1; Full text PubReader ePub PDF

Nanomedicines for Therapy of Bladder Cancer: Cheeun Song, Seung Ju Jang, Woo Hyeok Jeon, Sejung Maeng, Jong Hyun Tae, In Ho Chang; Korean J Urol Oncol. 2022;20(4):235-247. Published online November 30, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.4.235; Full text PubReader ePub PDF

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor With Upper Urinary Tract Carcinoma Who Underwent Radical Nephroureterectomy and Adjuvant Chemotherapy: Jee Hwan Yoon, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku, Ji Hyeong Yu, Hyeong Dong Yuk; Korean J Urol Oncol. 2022;20(1):34-42. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.34; Full text PubReader ePub PDF

Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy Followed by Radical Cystectomy: A Single-Center Retrospective Study: Jang Ho Cho, Ghee-Young Kwon, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han-Yong Choi, Su Jin Lee, Se Hoon Park; Korean J Urol Oncol. 2020;18(3):194-200. Published online December 30, 2020; DOI: https://doi.org/10.22465/kjuo.2020.18.3.194
Cited By 1; Full text PubReader ePub PDF

Update on Current Role of Perioperative Chemotherapy in Upper Tract Urothelial Carcinoma: Byeong Jo Jeon, Bum Sik Tae, Jae Young Park; Korean J Urol Oncol. 2018;16(3):89-96. Published online December 28, 2018; DOI: https://doi.org/10.22465/kjuo.2018.16.3.89; Full text PubReader ePub PDF

Clinical Outcomes of Continuous Addition of Androgen Deprivation Therapy During Docetaxel Chemotherapy for Patients With Castration-Resistant Prostate Cancer: Dong Hoon Lee, Jung Ho Kim, Won Ik Seo, Jong Kil Nam, Tae Nam Kim, Cheol Kyu Oh, Soo Dong Kim, Sung-Woo Park, Jae Sung Chung, Sang Hyun Park, Wan Lee, Gyung Tak Sung, Moon Kee Chung, Jae Il Chung; Korean J Urol Oncol. 2017;15(2):59-65. Published online August 29, 2017; DOI: https://doi.org/10.22465/kjuo.2017.15.2.59
Cited By 3; Full text PubReader ePub PDF

Chemotherapy in Advanced Urothelial Carcinoma: Yun-Sok Ha, Tae-Hwan Kim; Korean J Urol Oncol. 2016;14(2):47-53. Published online August 30, 2016; DOI: https://doi.org/10.22465/kjuo.2016.14.2.47
Cited By 3; Full text PubReader ePub PDF

Leukemoid Reaction, a Rare Paraneoplastic Syndrome in Urothelial Cell Carcinoma: Is It an Indicator of a Poor Prognosis?: Ho Seok Chung , Bo Sung Shin , Ho Song Yu , Eu Chang Hwang , Sun-Ouck Kim , Sung Il Jung , Taek Won Kang , Dong Deuk Kwon , Kwangsung Park; Korean J Urol Oncol. 2015;13(3):134-137. Published online December 30, 2015; PDF

Lymph Node-related Parameters as Prognostic Markers in Lymph Node Positive Bladder Cancer: Sangjun Yoo , In Gab Jeong; Korean J Urol Oncol. 2015;13(2):43-50. Published online August 30, 2015; PDF

Peri-Operative Intravesical Chemotherapy in the Treatment of Non-Muscle Invasive Bladder Cancer: Is It Necessary?: Myong Kim , Ja Hyeon Ku; Korean J Urol Oncol. 2013;11(3):109-115. Published online December 30, 2013; PDF

Optimal Cycles of Docetaxel-Based Systemic Chemotherapy in Men with Metastatic Castration-Resistant Prostate Cancer (CRPC): Sung Hoon Ahn , Seung Chol Park; Korean J Urol Oncol. 2013;11(2):105-108. Published online August 30, 2013; PDF

Risk Factors for Metastatic Castrate-Resistant Prostate Cancer: Jae Heon Kim , Won Jae Yang; Korean J Urol Oncol. 2013;11(1):6-10. Published online April 30, 2013; PDF

New Drugs for Castration-resistant Prostate Cancer: Hoon Choi , Jae Young Park , Hong Seok Park; Korean J Urol Oncol. 2012;10(3):124-129. Published online December 30, 2012; PDF

Update of Intravesical Therapy on Non-Muscle Invasive Bladder Cancer: Hyun Yul Rhew , Taek Sang Kim; Korean J Urol Oncol. 2009;7(1):6-11. Published online April 1, 2009; PDF

5,094	Complex Epidemiology of Prostate Cancer in Asian Countries
3,522	Current Update on Prostate Cancer Immunotherapy
3,206	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
3,105	Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
3,007	Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients

Cited By 10	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 7	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Search